Throat and laryngeal tumors, thyroid diseases
Conditions
Interventions
Experimental Group:The endoscopic surgical instrument control system (SP1000)
Sponsors
Zhejiang Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Aged 18-80 years (inclusive), regardless of gender; 2) Patients requiring surgical resection for throat, laryngeal tumors, or thyroid diseases who meet the following conditions: Benign tumors of the throat or larynx; T1 or T2 stage malignant tumors of the throat or larynx; Thyroid diseases suitable for endoscopic surgery; 3) No prior tumor treatment; 4) Willing and able to comply with the study protocol requirements; 5) Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1)Previously received head and neck radiotherapy, regardless of whether chemotherapy was administered; 2)Evidence of other primary cancers or distant metastasis, or participants with synchronous primary tumors (excluding skin cancer); 3)Anticipated need for microvascular soft tissue reconstruction surgery before operation; 4)Tumor invasion and/or close proximity to the internal carotid artery and/or external carotid artery; 5)Pharyngeal posterior cervical artery combined with tonsil cancer or posterior wall cancer; 6)Evidence of tumor invasion into the mandible. 7) Eastern Cooperative Oncology Group (ECOG) performance status greater than or equal to 2; 8) Currently using anticoagulant drugs and unable to stop them before surgery; 9) Contraindications to general anesthesia or surgery; 10) Mental disability or psychological disorders, or severe systemic diseases that prevent compliance with study requirements or inability to provide informed consent; 11) Pregnant or suspected pregnancy; 12) Difficulty in opening the mouth; 13) Thyroid tumors invading the trachea or esophagus, or extensive lymph node metastasis, with preoperative indications such as medullary carcinoma, poorly differentiated carcinoma, undifferentiated carcinoma, and invasive pathological subtypes of papillary thyroid carcinoma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of non-conversion surgery;Incidence of grade 3 or higher complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgery duration;Positive margin rate (%) [applicable to malignant tumors];Patient pain score;complication rate;Incidence of adverse events; | — |
Countries
China
Contacts
Public ContactMinghua Ge
Zhejiang Provincial People's Hospital
Outcome results
None listed